TRPV1 and neuroblastoma: Caballero et al. reported AM404, an antagonist of TRPV1 and CB1, inhibited NFAT transcriptional activity and, thus, downregulated MMP1, MMP2, and MMP7 in neuroblastoma SK-N-SH cells via a mechanism unrelated to TRPV1 116.